TREA

97584896 - INFINANT HEALTH

Follow

Information

  • Trademark
  • 97584896
  • Serial Number
    97584896
  • Filing Date
    September 09, 2022
    2 years ago
  • Transaction Date
    July 15, 2024
    5 months ago
  • Status Date
    July 15, 2024
    5 months ago
  • Published for Opposition Date
    October 17, 2023
    a year ago
  • Location Date
    December 12, 2023
    a year ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    STEINPFAD, SARAH E
  • Attorney Docket Number
    084193.00002
    Attorney Name
    John Gary Maynard, III
    Law Office Assigned Location Code
    N20
  • Owners
Information
Mark Drawing Code
3
Mark Identification
INFINANT HEALTH
Case File Statements
  • DM0000: The mark consists of six gold circles and the stylized wording "INFINANT HEALTH" in black.
  • CC0000: The color(s) black and gold is/are claimed as a feature of the mark.
  • DS0000: "HEALTH"
  • GS0421: Developing microbiome preparations for foods and medicines for use by mother and infant pairs; developing microbiome preparations for use in treating patients with atopic, allergic, inflammation, inflammatory conditions, infections, autoimmune, cognitive, metabolic disorders and diseases; development of microbiome preparations for pregnant women; development of microbiome preparations for the prevention and treatment of autism; development of microbiome preparations for older adults, elderly; Pharmaceutical and non-pharmaceutical product research and development; product research and development of medicines, nutritional and dietary supplements; Development of computer platforms technology for discovery and development of therapeutics for the treatment, prevention, palliation, and diagnosis of diseases; Research and development of products for the diagnosis of human disease or human health-related conditions; Research of non-pharmaceutical and pharmaceutical products for the prevention or treatment of human diseases or human health-related conditions; Development of computer platforms for discovery and development of research for therapeutics products for the reduction of risk, diagnosis, prevention, palliation, or treatment of human diseases or human health-related conditions; Medical and scientific research in the field(s) of infant gut microbiome health, maternal-infant health and wellness, infant health and wellness, preterm infant health and wellness; Research and development in the field(s) of maternal health, infant health, preterm infant health, gut health, immune health, namely, vaccine efficiency, and metabolic health; Biomedical research services related to health and clinical status of pregnant women, preterm infants, term infants, toddlers and children; Research and development of diagnostics for biological, behavioral, auditory, and pictorial health indicators; Medical and bioscience research services in the areas of the microbiome, immune system, metabolic systems of pregnant women, preterm infants, term infants, toddlers and children; Medical and bioscience research services in to the areas of the microbiome, immune system, and metabolic systems of older adults and elderly; Platform as a service (PAAS) featuring predictive, monitoring and diagnostic computer software platforms for caregivers and healthcare providers to monitor health and wellness of pregnant women, nursing mothers, caregivers, and their infants; development of consumer devices for recording and monitoring health attributes to work in conjunction with or related to live bacterial therapeutics or food products; Development of tools for measuring and tracking infant health data for purposes of evaluating effectiveness of treatment of diseases and medical conditions; Development of maternal and infant wellness tests and applications; Development of Software as a Medical Device (SaMD); Development of Machine Learning as a Medical Device (MLaMD); Development of downloadable mobile applications for monitoring, managing, and treating medical conditions and diseases
Case File Event Statements
  • 9/13/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 9/26/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/27/2022 - 2 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 12/7/2022 - 2 years ago
    4 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 2/17/2023 - a year ago
    5 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 2/17/2023 - a year ago
    6 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 2/17/2023 - a year ago
    7 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 6/7/2023 - a year ago
    8 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/8/2023 - a year ago
    9 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/8/2023 - a year ago
    10 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/8/2023 - a year ago
    11 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/7/2023 - a year ago
    12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/7/2023 - a year ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/8/2023 - a year ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/9/2023 - a year ago
    15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/17/2023 - a year ago
    17 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/17/2023 - a year ago
    18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 12/12/2023 - a year ago
    19 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 9/27/2023 - a year ago
    16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/15/2024 - 5 months ago
    20 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 7/15/2024 - 5 months ago
    21 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6